Autopsy report · NCT02524639

Sirolimus for the Treatment of Hyperinsulinism

“Due to strict inclusion and exclusion criteria no subjects were enrolled”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1, Phase 2

Sponsor

Children's Hospital of Philadelphia

Sponsor type

University, hospital or other

Conditions

Hyperinsulinism

Interventions

Sirolimus

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Evaluation of Dextenza in Patients With Ocular GVHD and Effects on Ocular Surface Disease Outcomes
  “Due to difficulty enrolling subjects whom had not meet the inclusion criteria” (85% match in meaning)
• Characterization of a Clinical Subpopulation in Children With Autism Spectrum Disorder
  “No subjects enrolled” (79% match in meaning)
• Acetazolamide for the Prevention of Post Operative CSF Leak
  “No participants were identified per inclusion/exclusion criteria” (79% match in meaning)
• Effects of Levothyroxine Treatment on Hemodynamic and Renal Functions in Subclinical Hypothyroidism
  “No patient corresponding to inclusion criteria couldn't be enrolled in the study” (77% match in meaning)
• Evaluating a Novel Method of EEG Evoked Response Potential Analysis in Concussion Assessment, Young Adults and Adults
  “No participant were enrolled” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.